Tamieka Lauz Hunter
0009-0003-9266-660X
George Washington University
1 paper found
Refreshing results…
Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia
Missing publications? Search for publications with a matching author name.